Skip Page Header

Home > Activity-based detection and bioanalytical confirmation of a fatal carfentanil intoxication.

Cannaert, Annelise and Ambach, Lars and Blanckaert, Peter and Stove, Christophe P (2018) Activity-based detection and bioanalytical confirmation of a fatal carfentanil intoxication. Frontiers in Pharmacology , 9 , (483) . https://doi.org/10.3389/fphar.2018.00486.

URL: https://www.frontiersin.org/articles/10.3389/fphar...

Carfentanil, one of the most potent opioids known, has recently been reported as a contaminant in street heroin in the United States and Europe, and is associated with an increased number of life-threatening emergency department admissions and deaths. Here, we report on the application of a novel in vitro opioid activity reporter assay and a sensitive bioanalytical assay in the context of a fatal carfentanil intoxication, revealing the highest carfentanil concentrations reported until now. A 21-year-old male was found dead at home with a note stating that he had taken carfentanil with suicidal intentions. A foil bag and plastic bag labeled “C.50” were found at the scene. These bags were similar to a sample obtained by the Belgian Early Warning System on Drugs from a German darknet shop and to those found in the context of a fatality in Norway. Blood, urine and vitreous, obtained during autopsy, were screened with a newly developed in vitro opioid activity reporter assay able to detect compounds based on their μ-opioid receptor activity rather than their chemical structure.

All extracts showed strong opioid activity. Results were confirmed by a bioanalytical assay, which revealed extremely high concentrations for carfentanil and norcarfentanil. It should be noted that carfentanil concentrations are typically in pg/mL, but here they were 92 ng/mL in blood, 2.8 ng/mL in urine, and 23 ng/mL in vitreous. The blood and vitreous contained 0.532 and 0.300 ng/mL norcarfentanil, respectively. No norcarfentanil was detected in urine. This is the first report where a novel activity-based opioid screening assay was successfully deployed in a forensic case. Confirmation and quantification using a validated bioanalytical procedure revealed the, to our knowledge, highest carfentanil concentrations reported in humans so far.


Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
Opioid
Intervention Type
Harm reduction, Screening / Assessment
Date
May 2018
Identification #
https://doi.org/10.3389/fphar.2018.00486
Publisher
Frontiers Media
Volume
9
Number
483
EndNote

Repository Staff Only: item control page